Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Gross Profit | 30,850 | 25,720 | 46,110 | 59,460 | 42,553 |
| Operating Expenses | 8,320 | 13,230 | 14,210 | 12,870 | 10,762 |
| Operating Income | -8,320 | -13,230 | -14,210 | -12,870 | -10,762 |
| Pre-tax Income | -8,320 | -13,230 | -14,210 | -12,870 | -10,762 |
| Net Income Continuous | -8,320 | -13,230 | -14,210 | -12,870 | -10,762 |
| Net Income | $-8,320 | $-13,230 | $-14,210 | $-12,870 | $-10,762 |
| EBITDA(a) | $-3,690 | $-6,430 | $-5,930 | $-4,430 | $-3,840 |